1. Home
  2. HLN

as of 03-12-2026 2:51pm EST

$10.11
+$0.11
+1.10%
Stocks Consumer Discretionary Package Goods/Cosmetics Nasdaq

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Founded: 2022 Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 43.7B IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 8.0M
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield:
1.81%
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $8.71 - $11.42 Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 7.04% Revenue Growth (next year): 4.58%
P/E Ratio: 49.05 Index: N/A
Free Cash Flow: N/A FCF Growth: +12.72%

Latest Haleon plc (Each representing two) News

HLN Breaking Stock News: Dive into HLN Ticker-Specific Updates for Smart Investing

All HLN News

Share on Social Networks: